Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”-Reference-Cited by-同舟云学术

Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”

Published:2023-08-01 Issue:4 Volume:13 Page:196-197
ISSN:2168-9709
Container-title:Mental Health Clinician
language:en
Short-container-title:

Author:

Todtenkopf Mark S.¹^ORCID,Correll Christoph U.²^ORCID,Harris-White Marni E.³^ORCID,Doane Michael J.⁴^ORCID,McDonnell David^ORCID

Affiliation:

1. 1 Director, Scientific Communications, Alkermes Inc, Waltham, Massachusetts

2. 2 Professor of Psychiatry, The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York; Professor of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, New York; Professor of Child and Adolescent Psychiatry and Department Chair, Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany

3. 3 Medical Director, Medical Affairs Strategy, Alkermes Inc, Waltham, Massachusetts

4. 4 Director, Health Economics & Outcomes Research, Alkermes Inc, Waltham, Massachusetts

Publisher

College of Psychiatric and Neurologic Pharmacists (CPNP)

Subject

Pharmacology (medical),Neurology (clinical),General Pharmacology, Toxicology and Pharmaceutics,Neuropsychology and Physiological Psychology

Link

https://meridian.allenpress.com/mhc/article-pdf/13/4/196/3245721/i2168-9709-13-4-196.pdf

Reference11 articles.

1. Opioid antagonists to prevent olanzapine-induced weight gain: a systematic review;Laguado;Ment Health Clin,2022

2. Mitigation of olanzapine-induced weight gain with samidorphan, an opioid antagonist: a randomized double-blind phase 2 study in patients with schizophrenia;Martin;Am J Psychiatry,2019

3. Effects of olanzapine combined with samidorphan on weight gain in schizophrenia: a 24-week phase 3 study;Correll;Am J Psychiatry,2020

4. Olanzapine/samidorphan in young adults with schizophrenia, schizophreniform disorder, or bipolar I disorder who are early in their illness: results of the ENLIGHTEN-Early study (NCT03187769) [oral presentation];Kahn

5. A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers;Silverman;Schizophr Res,2018